Log in
Enquire now
‌

US Patent 9358235 Kinase modulation, and indications therefor

Patent 9358235 was granted and assigned to Plexxikon Inc. on June, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Plexxikon Inc.
Plexxikon Inc.
Current Assignee
Plexxikon Inc.
Plexxikon Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9358235
Patent Inventor Names
Paul Lin0
Prabha N. Ibrahim0
Brian West0
Gideon Bollag0
Klaus-Peter Hirth0
Date of Patent
June 7, 2016
Patent Application Number
13802106
Date Filed
March 13, 2013
Patent Citations Received
‌
US Patent 12076322 Compounds and methods for kinase modulation, and indications therefor
0
Patent Primary Examiner
‌
Uma Ramachandran
Patent abstract

The present disclosure provides methods of using protein kinase inhibitors for treating diseases and conditions, including diseases and conditions associated with activity of any protein kinase selected from Fms protein kinase including any mutations thereof, Kit protein kinase any mutations thereof, Flt-3 protein kinase any mutations thereof and combinations thereof.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9358235 Kinase modulation, and indications therefor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.